Literature DB >> 23129399

The impairment of insulin signaling in Alzheimer's disease.

Emanuel Candeias1, Ana I Duarte, Cristina Carvalho, Sónia C Correia, Susana Cardoso, Renato X Santos, Ana I Plácido, George Perry, Paula I Moreira.   

Abstract

Alterations of the insulin signaling cascade underlie cognitive decline and the development of several neurodegenerative diseases. In recent years, a great interest has been put in studying the interaction between diabetes and Alzheimer's disease (AD). In fact, evidence shows that both diseases present several biochemical similarities including defects in the insulin signaling pathway. Here, we give an overview of the main functions of insulin in the central nervous system. The impact of insulin signaling impairment in brain aging and AD is also discussed. Finally, we present evidence supporting the notion that insulin is a link between diabetes and AD.
Copyright © 2012 International Union of Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23129399     DOI: 10.1002/iub.1098

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  22 in total

Review 1.  Metabolic Alterations Associated to Brain Dysfunction in Diabetes.

Authors:  João M N Duarte
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

2.  Experimental induction of type 2 diabetes in aging-accelerated mice triggered Alzheimer-like pathology and memory deficits.

Authors:  Jogender Mehla; Balwantsinh C Chauhan; Neelima B Chauhan
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

3.  MiR-126 Regulates Growth Factor Activities and Vulnerability to Toxic Insult in Neurons.

Authors:  Woori Kim; Haneul Noh; Yenarae Lee; Jeha Jeon; Arthi Shanmugavadivu; Donna L McPhie; Kwang-Soo Kim; Bruce M Cohen; Hyemyung Seo; Kai C Sonntag
Journal:  Mol Neurobiol       Date:  2014-11-19       Impact factor: 5.590

4.  A derangement of the brain wound healing process may cause some cases of Alzheimer's disease.

Authors:  Steven Lehrer; Peter H Rheinstein
Journal:  Discov Med       Date:  2016-08       Impact factor: 2.970

Review 5.  Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.

Authors:  Eugene J Barrett; Zhenqi Liu; Mogher Khamaisi; George L King; Ronald Klein; Barbara E K Klein; Timothy M Hughes; Suzanne Craft; Barry I Freedman; Donald W Bowden; Aaron I Vinik; Carolina M Casellini
Journal:  J Clin Endocrinol Metab       Date:  2017-12-01       Impact factor: 5.958

6.  Insulin Modulates Excitatory Synaptic Transmission and Synaptic Plasticity in the Mouse Hippocampus.

Authors:  Fangli Zhao; Jason J Siu; Wei Huang; Candice Askwith; Lei Cao
Journal:  Neuroscience       Date:  2019-05-28       Impact factor: 3.590

Review 7.  Gut-brain connection: The neuroprotective effects of the anti-diabetic drug liraglutide.

Authors:  Emanuel Monteiro Candeias; Inês Carolina Sebastião; Susana Maria Cardoso; Sónia Catarina Correia; Cristina Isabel Carvalho; Ana Isabel Plácido; Maria Sancha Santos; Catarina Resende Oliveira; Paula Isabel Moreira; Ana Isabel Duarte
Journal:  World J Diabetes       Date:  2015-06-25

Review 8.  Prospective of managing impaired brain insulin signalling in late onset Alzheimers disease with excisting diabetic drugs.

Authors:  Gifty M Jojo; Gowthamarajan Kuppusamy; Kousalya Selvaraj; Uday Krishna Baruah
Journal:  J Diabetes Metab Disord       Date:  2019-05-09

9.  Glucose levels and risk of dementia.

Authors:  Paul K Crane; Rod Walker; Rebecca A Hubbard; Ge Li; David M Nathan; Hui Zheng; Sebastien Haneuse; Suzanne Craft; Thomas J Montine; Steven E Kahn; Wayne McCormick; Susan M McCurry; James D Bowen; Eric B Larson
Journal:  N Engl J Med       Date:  2013-08-08       Impact factor: 91.245

10.  Distinctive RNA expression profiles in blood associated with Alzheimer disease after accounting for white matter hyperintensities.

Authors:  Zhouxian Bai; Boryana Stamova; Huichun Xu; Bradley P Ander; Jiajia Wang; Glen C Jickling; Xinhua Zhan; DaZhi Liu; Guangchun Han; Lee-Way Jin; Charles DeCarli; Hongxing Lei; Frank R Sharp
Journal:  Alzheimer Dis Assoc Disord       Date:  2014 Jul-Sep       Impact factor: 2.703

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.